MAPT and Alzheimer disease: Given its role in reducing neuroinflammation, regulating Aβ metabolism, and protecting against tau pathology, targeting serotonin signaling pathways could offer a promising therapeutic approach for mitigating cognitive decline and neurodegeneration in AD.